APRIL MATTHEWS: Open Payments
NPI 1992267389 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 67 payments from 13 companies in 2025. Trend: 2023 $166 · 2024 $1,488 · 2025 $1,640
Food & beverage: $1,540Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $563 |
| ABBVIE INC. | 23 | $334 |
| Incyte Corporation | 8 | $314 |
| UCB, Inc. | 3 | $83 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $78 |
| Biofrontera Inc. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| LEO Pharma Inc. | 2 | $38 |
| Surgenex LLC | 1 | $28 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
Products named: TREMFYA, OPZELURA, RINVOQ, SKYRIZI, Bimzelx, ILUMYA, Winlevi, COSENTYX.
Industry payments across CA — which companies pay providers there.
